DataHow Secures Series A Funding for Bioprocess AI Platform

DataHow, a Zurich-based Swiss technology company specializing in bioprocess data analytics and modelling, has raised a Series A funding round. The round was led by Momenta Ventures, with participation from Zürcher Kantonalbank, HINA Bioventures, and Rockwell Automation. The funding was announced on September 2, 2026. The exact amount was not disclosed.

What DataHow Does

DataHow offers a cloud platform called DataHowLab that combines a priori process knowledge with data-driven AI and real-time digital twin technology. This helps process engineers develop better bioprocesses with less experimental effort, time, and cost. The platform is used in biopharmaceutical development and manufacturing, and the company works with many of the industry's largest manufacturers, including 12 of the top 20 Big Pharma companies. DataHow is extending its platform from upstream into downstream bioprocessing.

Company Background

DataHow is headquartered in Zurich, Switzerland. The company's technology aims to improve efficiency and reduce costs in bioprocess development.

Funding Details

The Series A round was led by Momenta Ventures, a strategic investor in industrial technology. The participation of Rockwell Automation, a major industrial automation company, suggests potential synergies in the industrial and bioprocessing sectors. The funding will likely support DataHow's expansion into downstream bioprocessing and further development of its platform.

Investors

• Lead Investor: Momenta Ventures
• Other Investors: Zürcher Kantonalbank, HINA Bioventures, Rockwell Automation

This investment underscores the growing importance of AI and digital twins in biopharmaceutical manufacturing.